Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference86 articles.
1. Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors;Strosberg;N Engl J Med,2017
2. Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival;Kwekkeboom;J Clin Oncol,2008
3. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors;Kwekkeboom;Endocr Relat Cancer,2010
4. Results and adverse events of personalized peptide receptor radionuclide therapy with 90Yttrium and 177Lutetium in 1048 patients with neuroendocrine neoplasms;Baum;Oncotarget,2018
5. Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors;Bodei;Eur J Nucl Med Mol Imaging,2015
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pan-cancer analysis of COL15A1: an immunological and prognostic biomarker;Discover Oncology;2024-08-01
2. Imaging-guided companion diagnostics in radiotherapy by monitoring APE1 activity with afterglow and MRI imaging;Nature Communications;2024-07-28
3. Immune Response to Molecular Radiotherapy with 177Lu-DOTATOC: Predictive Value of Blood Cell Counts for Therapy Outcome;Cancer Biotherapy and Radiopharmaceuticals;2024-06-21
4. Evaluation of a blood miRNA/mRNA signature to follow-up Lu-PRRT therapy for G1/G2 intestinal neuroendocrine tumors;Frontiers in Endocrinology;2024-06-14
5. Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine;Journal of Nuclear Medicine;2024-04-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3